Real-world data (RWD) refers to health-related data collected from sources such as electronic health records (EHRs), insurance claims, patient registries, and patient-reported outcomes. This data offers invaluable insights that can drive innovation, inform clinical decision-making, and enhance patient care.
To unlock the full potential of RWD, data from different sources needs to be transformed into real-world data products—structured, analysis-ready datasets that are curated, standardized, and quality-controlled for specific research or clinical use cases. These data products enable researchers and clinicians to efficiently generate real-world evidence (RWE)—the clinical evidence regarding the usage and potential benefits or risks of medical products derived from the analysis of RWD.
However, transforming raw RWD into high-quality, analysis-ready data products that meet regulatory standards poses unique challenges. Issues such as data variability, missing information, and privacy concerns must be addressed to ensure the data’s reliability and compliance. In this blog, we will explore these challenges and discuss strategies to effectively create robust RWD products that can support impactful, regulatory-grade real-world evidence.